American Society of Clinical Oncology

#ASCO26 truly embodied the theme of translating science into global patient outcomes. We are grateful to the ~46,000 attendees, all working tirelessly to conquer cancer together! A heartfelt thanks to all. 💗 We can’t wait to see you next year at #ASCO27!

📲Using a mobile app for weekly symptom monitoring can help ppl w adv. cancer better maintain QoL & reduce their need for unplanned hospitalization. @fumikochino.bsky.social breaks down this research presented at #ASCO26. Read the abstract: https://bit.ly/4fwqV47

Take an escalator ride w Dr Yara Abdou as she gives a quick snapshot of her #ASCO26 abstract. Her research, funded by a @conquercancer.bsky.social Career Development Award, evaluates clinical implications of post-surgical ctDNA surveillance in pts w high-risk early-stage TNBC: https://bit.ly/3RYBXFj

Room S100bc at #ASCO26 is popping, everyone here to learn about #Melanoma and #SkinCancer: https://bit.ly/4fdLpOP #melsm

Major news from #ASCO26: A multi-selective RAS(ON) inhibitor nearly doubles survival time in people with metastatic pancreatic cancer. “This is absolutely practice-changing” says Dr. Shruti Patel in this Science in Seconds. #pancan Read the abstract: https://bit.ly/4dChEWM

Results from HARMONi-6 study show ivonescimab may improve OS in pts w adv. squamous non-small cell #LungCancer. @lungoncdoc.bsky.social explains what you need to know. Read the abstract: https://bit.ly/43yLR2T

News from #ASCO26: SARC041 trial shows targeted CDK4/6 inhibitor abemaciclib slows tumor growth in recurrent dedifferentiated #liposarcoma. Dr. Dale Shepard breaks down this data in our latest Science in Seconds.  Read the abstract: https://bit.ly/4adk1gk

Phase 3 PROTEUS study, presented at #ASCO26, found a potential new targeted treatment (apalutamide+ADT) option for ppl w local High⬆️ risk #ProstateCancer. @williamohmd.bsky.social weighs in. Read the abstract: https://bit.ly/3Rz7vl2

While riding the escalator w us @ #ASCO26, Dr Nazli Dizman shares a quick overview of her abstract 9575, investigating whether microbiome-derived metabolites a role in the interaction btwn a high-fiber diet & outcomes w ICBs—research funded by @conquercancer.bsky.social #YIA: https://bit.ly/4uGJozo

Dr. Nicholas Hornstein shares a quick overview of his abstract, e15507, published in @jco-asco.bsky.social & funded by a @conquercancer.bsky.social #YIA grant, while riding the escalator with us at #ASCO26. Read the abstract: https://bit.ly/43pxT3D

Some breast cancer patients with sentinel lymph node spread can safely skip axillary lymph node dissection, helping them avoid lasting arm-related side effects according to new research presented at #ASCO26. Our President Elect Dr. Elizabeth Mittendorf explains. #bcsm https://bit.ly/4wV0xqw

Overflow room needed for packed #ASCO26 joint session with @theaacr.bsky.social on the story of targeting KRAS, clinical updates on KRAS inhibitors, and novel approaches to targeting KRAS chaired by ASCO President Dr. Eric Small & AACR President Dr. Lillian Siu. Livestream going in room S100a.

What’s the role of #GLP-1s in cancer care? Research presented at #ASCO26, examining real-world data shows GLP-1s may reduce metastatic progression of certain #obesity-related cancers: lung, breast, colorectal & liver. @jrgralow.bsky.social explains in this Science in Seconds. https://bit.ly/3Q5Ya3G

Whether you need tech assistance or a toothpick, stop by our customer service area at #ASCO26, ASCO Central in the North Building, Level 3. We’ve got member services, CE & tech help, interpreters, hotel assistance, the ASCO store, & more!

New research from #ASCO26 shows that fasting before and after chemo may help reduce insulin levels and may help improve tx response for certain people with #ovariancancer. @drteplinsky.bsky.social explains more in our latest Science in Seconds: https://bit.ly/4f7z1Qm #gyncsm

Spotted at McCormick Place! 👋 Our CEO Dr. Clifford Hudis is ready to kick off #ASCO26 with our incredible global community. If you spot him between sessions, make sure to say hello!

Experience world-class science at an ASCO meeting in Singapore this June or online. Don't miss connecting with peers & hearing about the latest oncology advances. #ASCOBT26 is The Place to Be. Early registration ends May 20; reserve your spot: https://bit.ly/3QX1xu1

During #ASCOAdvocacySummit, we talked to participants about the value of oncology professionals working together to talk to lawmakers about cancer care & research priorities. Hear what they had to say and how you can get involved in advocacy, too: https://bit.ly/3R88atm